SCHEMBL4813756

SCHEMBL4813756

Cc1ccc(C(c2cccc3ccccc23)C(C#N)C#N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SLC6A4 P31645 2/20 0.36
SLC6A2 P23975 1/20 0.36
CYP2A6 P11509 1/20 0.35
MAPT P10636 3/20 0.34
LTC4S Q16873 1/20 0.34
MYB P10242 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4822975 0.84 PBRM1 (0.46) ALDH1A1SLC6A4SLC6A2MAPTHPGD
SCHEMBL4822950 0.84 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL29031364 0.81 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL4816018 0.81 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL4661572 0.81 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL4660010 0.77 GAA (0.42) ALDH1A1SLC6A4SLC6A2LTC4SHPGD
SCHEMBL4816417 0.76 SLC6A2 (0.43) CYP1A2CYP2C9CYP2C19SLC6A4SLC6A2
SCHEMBL4813877 0.76 SLC6A4 (0.43) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL13938653 0.75 SLC6A4 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4
SCHEMBL10137032 0.72 ADRA2A (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425580-B2 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2008-09-16 US claimed
EP-1747192-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2007-01-31 EP claimed
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2006-01-19 US claimed
WO-2005121076-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2005-12-22 WO claimed
US-7425580-B2 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2008-09-16 US disclosed
EP-1747192-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2007-01-31 EP disclosed
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2006-01-19 US disclosed
WO-2005121076-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands ESR1, ESR2, GPER1 ALDH1A1 409/4885CYP1A2 104/4885CYP2C9 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.